Source: Cancer Research. Unidades: IFSC, IB, FM, ICB
Subjects: NEOPLASIAS PROSTÁTICAS, GENÉTICA MÉDICA, ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IUGHETTI, P et al. A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Cancer Research, v. 61, n. 20, p. 7375-7378, 2001Tradução . . Disponível em: https://aacrjournals.org/cancerres/article/61/20/7375/508043/A-Polymorphism-in-Endostatin-an-Angiogenesis. Acesso em: 18 ago. 2024.APA
Iughetti, P., Suzuki, O., Godoi, P. H. C., Alves, V. A. F., Sertie, A. L., Zorick, T., et al. (2001). A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Cancer Research, 61( 20), 7375-7378. Recuperado de https://aacrjournals.org/cancerres/article/61/20/7375/508043/A-Polymorphism-in-Endostatin-an-AngiogenesisNLM
Iughetti P, Suzuki O, Godoi PHC, Alves VAF, Sertie AL, Zorick T, Soares F, Camargo A, Moreira ES, Di Loreto C, Moreira-Filho CA, Simpson A, Oliva G, Passos-Bueno MR. A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma [Internet]. Cancer Research. 2001 ; 61( 20): 7375-7378.[citado 2024 ago. 18 ] Available from: https://aacrjournals.org/cancerres/article/61/20/7375/508043/A-Polymorphism-in-Endostatin-an-AngiogenesisVancouver
Iughetti P, Suzuki O, Godoi PHC, Alves VAF, Sertie AL, Zorick T, Soares F, Camargo A, Moreira ES, Di Loreto C, Moreira-Filho CA, Simpson A, Oliva G, Passos-Bueno MR. A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma [Internet]. Cancer Research. 2001 ; 61( 20): 7375-7378.[citado 2024 ago. 18 ] Available from: https://aacrjournals.org/cancerres/article/61/20/7375/508043/A-Polymorphism-in-Endostatin-an-Angiogenesis